drugset
Drugs / patient-specific, soluble protein idiotype vaccine
last change Sep 2022 re-read 3 minutes ago

patient-specific, soluble protein idiotype vaccine

Vaccine

Developed for
follicular lymphoma
Investigated by
Center for Applied Medical Research (Centro de Investigación Médica Aplicada) · Clinica Universidad de Navarra, Universidad de Navarra · University of Navarrra Hospital (Clinica Universitaria)

Trials 1

today NCT00530140 · Ph 2
20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00530140 Oct 2007 → Sep 2013 follicular lymphoma Clinica Universidad de Navarra, Universidad de Navarra Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as patient-specific, soluble protein idiotype vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT00530140 ↗
Modality Vaccine “soluble protein idiotype vaccine” NCT00530140 ↗